Drug
Ionis Hbvrx
Ionis Hbvrx: highest development phase Phase 2, developed by GlaxoSmithKline. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| IONIS-HBVRx NCT02981602 | Phase 2 | Hepatitis B |
Latest
No recent events.
Follow Ionis Hbvrx on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.